NVP Associates
MENLO PARK, CAfiles as NVP ASSOCIATES, LLC
$328m in 7 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 31.7% of the portfolio this quarter.
Value
$328m
Stocks
7
Top 10 share
100.0%
Turnover
31.7%
What changed this quarter
New
Bought for the first time this quarter.
- Avalyn PharmaAVLN22.8% of the fund
- SnowflakeSNOW8.9% of the fund
- OndasONDS<0.1% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- BillionToOneBLLN-100%
Holdings
- Avalyn PharmaAVLN
- Share
- 22.8%
- Value
- $75m
- Shares
- 2,268,404
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| MBX BiosciencesMBX | 35.9% | $118m | 2,136,335 | Held |
| Avalyn PharmaAVLN | 22.8% | $75m | 2,268,404 | New |
| Omada HealthOMDA | 16.9% | $56m | 2,531,000 | Held |
| Zenas BioPharmaZBIO | 14.2% | $47m | 1,838,482 | Held |
| SnowflakeSNOW | 8.9% | $29m | 114,786 | New |
| Grove Collaborative HoldingsGROV | 1.2% | $4m | 3,225,097 | Held |
| OndasONDS | <0.1% | $128,560 | 15,602 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 78.2% since 30 June 2025.
Where the money is
Health care89.8%
Technology8.9%
Retail & consumer1.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.